Table 1.

Baseline characteristics of controls and cases.

	Controls (n=1,879)	Cases (n=832)	p-value
ApoC-III, mg/dL	4.8 (3.5–6.9)	5.5 (3.8–7.9)	<0.001
Age, years	65.3 ±7.7	65.6 ±7.7	0.46
Sex, male	1174(62.5%)	520 (62.5%)	0.99
Body mass index, kg/m2	26.3 ±3.5	27.3 ±3.8	<0.001
Current smoking	157 (8.4%)	127(15.4%)	<0.001
Systolic blood pressure, mmHg	139 ±18	144 ±19	<0.001
Diastolic blood pressure, mmHg	84 ±11	86 ±12	<0.001
Diabetes mellitus	33 (1.8%)	57 (6.9%)	<0.001
Lipid-lowering drugs	20 (1.1%)	31 (3.7%)	<0.001
Anti-hypertensive drugs	329 (17.5%)	352(42.3%)	<0.001
Total cholesterol, mmol/L	6.3 ±1.2	6.5 ±1.2	<0.001
LDL cholesterol, mmol/L	4.1 ±1.0	4.3 ±1.0	<0.001
HDL cholesterol, mmol/L	1.4 ±0.4	1.3 ±0.4	<0.001
Triglycerides, mmol/L	1.7 (1.2–2.3)	2.0 (1.4–2.8)	<0.001
Remnant cholesterol, mmol/L	0.7 (0.5–1.0)	0.8 (0.6–1.2)	<0.001
Apolipoprotein A-I, mg/dL	162.2 ±28.9	154.6 ±29.3	<0.001
Apolipoprotein B, mg/dL	129.1 ±31.2	137.6 ±32.7	<0.001
Lipoprotein(a), mg/dL	8.4 (6.4–13.6)	9.5 (6.9–24.7)	<0.001

Continuous variables with a normal distribution are reported as mean ± standard deviation. Continuous variables with a non-normal distribution are reported as median (interquartile range). Dichotomous variables are reported as percentage of total cohort (number). P-values are for student’ s T-test for continuous variables and X² test for dichotomous variables.